In the Syrian hamster PC model, oncolytic Vaccinia virus expressing human GM-CSF can enhance specific anti-tumor immune responses by recruitment and activation of natural killer cells, monocytes, and granulocytes to enhance the anti-tumor effect. This evidence concerns the gene CSF2 and pachyonychia congenita.